135795-46-9

Basic information

• Product Name: 3-AMINO-2-BROMO-6-METHOXYPYRIDINE
• Synonyms: 2-Bromo-6-methoxy-3-pyridinamine;5-AMino-6-broMo-2-Methoxypyridine;3-AMINO-2-CHLORO-6-METHOXYPYRIDINE;3-AMINO-2-BROMO-6-METHOXYPYRIDINE;2-BROMO-3-AMINO-6-METHOXYPYRIDINE;3-Amino-2-bromo-6-methoxypyridine ,97%
• CAS NO: 135795-46-9
• Molecular Formula: C6H7BrN2O
• Molecular Weight: 203.04
• EINECS: 251-989-2
• Product Categories: amine| alkyl bromide;Pyridine;Pyridines
• Mol File: 135795-46-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 293.927 °C at 760 mmHg
• Flash Point: 131.562 °C
• Appearance: /
• Density: 1.623 g/cm³
• Vapor Pressure: 0.00167mmHg at 25°C
• Refractive Index: 1.602
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 1.12±0.10(Predicted)
• CAS DataBase Reference: 3-AMINO-2-BROMO-6-METHOXYPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AMINO-2-BROMO-6-METHOXYPYRIDINE(135795-46-9)
• EPA Substance Registry System: 3-AMINO-2-BROMO-6-METHOXYPYRIDINE(135795-46-9)

Safety Data

• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 135795-46-9(Hazardous Substances Data)

Usage

Chemical Properties

Dark red solid

InChI:InChI=1/C6H7BrN2O/c1-10-5-3-2-4(8)6(7)9-5/h2-3H,8H2,1H3

Upstream product

• 6628-77-9 6-methoxy-pyridin-3-ylamine 
• 344296-05-5 2-bromo-6-methoxy-3-nitropyridine 

Downstream Products

• 27017-70-5 1,5-dihydro-1,5-naphthyridine-2,6-dione 
• 27017-64-7 6-methoxy-1,5-naphthyridin-2(1H)-one 
• 1027276-16-9 [4-(5-Ethyl-10-methyl-11-oxo-10,11-dihydro-5H-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-7-yl)-phenyl]-carbamic acid tert-butyl ester 
• 1026504-03-9 7-(6-Benzylamino-pyridin-3-yl)-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one 
• 1027228-66-5 7-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-5-ethyl-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one 
• 169833-59-4 5-Ethyl-7-(3-methoxy-phenyl)-10-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one 

Relevant articles and documents

BICYCLIC PYRIDONE LACTAMS AND METHODS OF USE THEREOF

The invention provides novel compounds having the general formula (I) wherein R1, X, Zlto Z5, L, n, the A ring, and the B ring, are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.Compounds (I) act as inhibitors of RIP1 kinase.

Preparation of azaindolines and benzoyl substituted azaindolines: Precursors of triazabenzo[cd]azulen-9-one PDE4 inhibitors

The syntheses of various substituted azaindolines are described. Azaindolines were identified as potential key intermediates towards new PDE4 inhibitors.

1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO

Compounds of Formula (IA), IB), IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.